DNM1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62503344114384E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62525548574877E-12 |
Normal-vs-Stage2 |
8.79299999478889E-08 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
5.05862018940206E-12 |
Stage1-vs-Stage2 |
2.722200E-01 |
Stage1-vs-Stage3 |
9.572100E-02 |
Stage1-vs-Stage4 |
9.592200E-01 |
Stage2-vs-Stage3 |
6.903700E-02 |
Stage2-vs-Stage4 |
3.633800E-01 |
Stage3-vs-Stage4 |
2.926200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
1.63902225125412E-12 |
Normal-vs-Asian |
4.45819999994601E-06 |
Caucasian-vs-AfricanAmerican |
6.667800E-01 |
Caucasian-vs-Asian |
4.548400E-02 |
AfricanAmerican-vs-Asian |
1.590620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.15463194561016E-14 |
Male-vs-Female |
1.278170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.16490000873415E-09 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
8.48999759384128E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.934000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.332200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.694800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.382300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.377600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.905400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.366200E-04 |
Normal-vs-Grade 2 |
1.11022302462516E-16 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
1.09859898955733E-11 |
Grade 1-vs-Grade 2 |
5.859800E-01 |
Grade 1-vs-Grade 3 |
5.437600E-02 |
Grade 1-vs-Grade 4 |
5.380800E-01 |
Grade 2-vs-Grade 3 |
8.716300E-03 |
Grade 2-vs-Grade 4 |
7.725800E-01 |
Grade 3-vs-Grade 4 |
1.930640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62492241884138E-12 |
Normal-vs-ccB subtype |
1.63935531816151E-12 |
ccA subtype-vs-ccB subtype |
9.558000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
7.785900E-04 |
N0-vs-N1 |
3.758200E-01 |
|
|